These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12071579)

  • 21. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic effects and cholesterol-lowering therapy.
    Shaw SM; Fildes JE; Yonan N; Williams SG
    Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin, like aspirin, should be given as early as possible in patients with acute coronary syndrome.
    Fang CH; Li JJ; Hui RT
    Med Hypotheses; 2005; 64(1):192-6. PubMed ID: 15533640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.
    Robinson JG; Smith B; Maheshwari N; Schrott H
    J Am Coll Cardiol; 2005 Nov; 46(10):1855-62. PubMed ID: 16286171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
    Katz MS
    Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do structural differences in statins correlate with clinical efficacy?
    Arnaboldi L; Corsini A
    Curr Opin Lipidol; 2010 Aug; 21(4):298-304. PubMed ID: 20581679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.
    Arnaud C; Burger F; Steffens S; Veillard NR; Nguyen TH; Trono D; Mach F
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1231-6. PubMed ID: 15790934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
    Bleske BE; Nicklas JM; Bard RL; Brook RD; Gurbel PA; Bliden KP; Rajagopalan S; Pitt B
    J Am Coll Cardiol; 2006 Jan; 47(2):338-41. PubMed ID: 16412857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of statins beyond lipid lowering: potential for clinical benefits.
    Almuti K; Rimawi R; Spevack D; Ostfeld RJ
    Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with statins and omega-3 fatty acids.
    Nambi V; Ballantyne CM
    Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?
    Neal DA; Alexander GJ
    Liver Transpl; 2001 Dec; 7(12):1009-14. PubMed ID: 11753902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antiinflammatory effects of statins.
    McCullough PA
    N Engl J Med; 2001 Oct; 345(16):1209; author reply 1210-1. PubMed ID: 11642241
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of statin therapy on colorectal cancer.
    Bardou M; Barkun A; Martel M
    Gut; 2010 Nov; 59(11):1572-85. PubMed ID: 20660702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Unstable atheromatous plaque. Physiopathology and therapeutic approach to coronary insufficiency].
    Berkenboom G
    Rev Med Brux; 2001 Dec; 22(6):497-502. PubMed ID: 11811045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective.
    Makris GC; Geroulakos G; Makris MC; Mikhailidis DP; Falagas ME
    Expert Opin Investig Drugs; 2010 Jul; 19(7):809-14. PubMed ID: 20470189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins in community acquired pneumonia: Evidence from experimental and clinical studies.
    Chalmers JD; Short PM; Mandal P; Akram AR; Hill AT
    Respir Med; 2010 Aug; 104(8):1081-91. PubMed ID: 20447815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins and other agents for vascular inflammation.
    Owens CD
    J Vasc Surg; 2012 Dec; 56(6):1799-806. PubMed ID: 23017371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease in chronic obstructive pulmonary disease.
    Hunninghake DB
    Proc Am Thorac Soc; 2005; 2(1):44-9. PubMed ID: 16113468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE.
    Katz MS; Carroll PR; Cowan JE; Chan JM; D'Amico AV
    BJU Int; 2010 Sep; 106(5):627-32. PubMed ID: 20151961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance.
    Biasucci LM; Biasillo G; Stefanelli A
    Clin Chem Lab Med; 2010 Dec; 48(12):1685-91. PubMed ID: 20868311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.